Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer

Innovation and implementation, June 16th and 17th 2016, Trondheim, Norway

Ana I. Robles, Karina Standahl Olsen, Dana W T Tsui, Vassilis Georgoulias, Jenette Creaney, Katalin Dobra, Mogens Vyberg, Nagahiro Minato, Robert A Anders, Anne Lise Børresen-Dale, Jianwei Zhou, Pål Sætrom, Boye Schnack Nielsen, Michaela B. Kirschner, Hans E. Krokan, Vassiliki Papadimitrakopoulou, Ioannis Tsamardinos, Oluf D. Røe

Research output: Contribution to journalArticle

Abstract

The goal of biomarker research is to identify clinically valid markers. Despite decades of research there has been disappointingly few molecules or techniques that are in use today. The "1st International NTNU Symposium on Current and Future Clinical Biomarkers of Cancer: Innovation and Implementation", was held June 16th and 17th 2016, at the Knowledge Center of the St. Olavs Hospital in Trondheim, Norway, under the auspices of the Norwegian University of Science and Technology (NTNU) and the HUNT biobank and research center. The Symposium attracted approximately 100 attendees and invited speakers from 12 countries and 4 continents. In this Symposium original research and overviews on diagnostic, predictive and prognostic cancer biomarkers in serum, plasma, urine, pleural fluid and tumor, circulating tumor cells and bioinformatics as well as how to implement biomarkers in clinical trials were presented. Senior researchers and young investigators presented, reviewed and vividly discussed important new developments in the field of clinical biomarkers of cancer, with the goal of accelerating biomarker research and implementation. The excerpts of this symposium aim to give a cutting-edge overview and insight on some highly important aspects of clinical cancer biomarkers to-date to connect molecular innovation with clinical implementation to eventually improve patient care.

Original languageEnglish (US)
Article number295
JournalJournal of Translational Medicine
Volume14
Issue number1
DOIs
StatePublished - Oct 19 2016

Fingerprint

Norway
Tumor Biomarkers
Innovation
Biomarkers
Research
Tumors
Research Personnel
Circulating Neoplastic Cells
Bioinformatics
Computational Biology
Patient Care
Cells
Clinical Trials
Urine
Technology
Plasmas
Molecules
Fluids
Serum
Neoplasms

Keywords

  • Bioinformatics
  • Circulating biomarkers
  • Circulating tumor cells
  • DNA repair
  • Early detection
  • Early diagnosis

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer : Innovation and implementation, June 16th and 17th 2016, Trondheim, Norway. / Robles, Ana I.; Olsen, Karina Standahl; Tsui, Dana W T; Georgoulias, Vassilis; Creaney, Jenette; Dobra, Katalin; Vyberg, Mogens; Minato, Nagahiro; Anders, Robert A; Børresen-Dale, Anne Lise; Zhou, Jianwei; Sætrom, Pål; Nielsen, Boye Schnack; Kirschner, Michaela B.; Krokan, Hans E.; Papadimitrakopoulou, Vassiliki; Tsamardinos, Ioannis; Røe, Oluf D.

In: Journal of Translational Medicine, Vol. 14, No. 1, 295, 19.10.2016.

Research output: Contribution to journalArticle

Robles, AI, Olsen, KS, Tsui, DWT, Georgoulias, V, Creaney, J, Dobra, K, Vyberg, M, Minato, N, Anders, RA, Børresen-Dale, AL, Zhou, J, Sætrom, P, Nielsen, BS, Kirschner, MB, Krokan, HE, Papadimitrakopoulou, V, Tsamardinos, I & Røe, OD 2016, 'Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: Innovation and implementation, June 16th and 17th 2016, Trondheim, Norway', Journal of Translational Medicine, vol. 14, no. 1, 295. https://doi.org/10.1186/s12967-016-1059-6
Robles, Ana I. ; Olsen, Karina Standahl ; Tsui, Dana W T ; Georgoulias, Vassilis ; Creaney, Jenette ; Dobra, Katalin ; Vyberg, Mogens ; Minato, Nagahiro ; Anders, Robert A ; Børresen-Dale, Anne Lise ; Zhou, Jianwei ; Sætrom, Pål ; Nielsen, Boye Schnack ; Kirschner, Michaela B. ; Krokan, Hans E. ; Papadimitrakopoulou, Vassiliki ; Tsamardinos, Ioannis ; Røe, Oluf D. / Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer : Innovation and implementation, June 16th and 17th 2016, Trondheim, Norway. In: Journal of Translational Medicine. 2016 ; Vol. 14, No. 1.
@article{021c174375da4ed8b48aefccd6868083,
title = "Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: Innovation and implementation, June 16th and 17th 2016, Trondheim, Norway",
abstract = "The goal of biomarker research is to identify clinically valid markers. Despite decades of research there has been disappointingly few molecules or techniques that are in use today. The {"}1st International NTNU Symposium on Current and Future Clinical Biomarkers of Cancer: Innovation and Implementation{"}, was held June 16th and 17th 2016, at the Knowledge Center of the St. Olavs Hospital in Trondheim, Norway, under the auspices of the Norwegian University of Science and Technology (NTNU) and the HUNT biobank and research center. The Symposium attracted approximately 100 attendees and invited speakers from 12 countries and 4 continents. In this Symposium original research and overviews on diagnostic, predictive and prognostic cancer biomarkers in serum, plasma, urine, pleural fluid and tumor, circulating tumor cells and bioinformatics as well as how to implement biomarkers in clinical trials were presented. Senior researchers and young investigators presented, reviewed and vividly discussed important new developments in the field of clinical biomarkers of cancer, with the goal of accelerating biomarker research and implementation. The excerpts of this symposium aim to give a cutting-edge overview and insight on some highly important aspects of clinical cancer biomarkers to-date to connect molecular innovation with clinical implementation to eventually improve patient care.",
keywords = "Bioinformatics, Circulating biomarkers, Circulating tumor cells, DNA repair, Early detection, Early diagnosis",
author = "Robles, {Ana I.} and Olsen, {Karina Standahl} and Tsui, {Dana W T} and Vassilis Georgoulias and Jenette Creaney and Katalin Dobra and Mogens Vyberg and Nagahiro Minato and Anders, {Robert A} and B{\o}rresen-Dale, {Anne Lise} and Jianwei Zhou and P{\aa}l S{\ae}trom and Nielsen, {Boye Schnack} and Kirschner, {Michaela B.} and Krokan, {Hans E.} and Vassiliki Papadimitrakopoulou and Ioannis Tsamardinos and R{\o}e, {Oluf D.}",
year = "2016",
month = "10",
day = "19",
doi = "10.1186/s12967-016-1059-6",
language = "English (US)",
volume = "14",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer

T2 - Innovation and implementation, June 16th and 17th 2016, Trondheim, Norway

AU - Robles, Ana I.

AU - Olsen, Karina Standahl

AU - Tsui, Dana W T

AU - Georgoulias, Vassilis

AU - Creaney, Jenette

AU - Dobra, Katalin

AU - Vyberg, Mogens

AU - Minato, Nagahiro

AU - Anders, Robert A

AU - Børresen-Dale, Anne Lise

AU - Zhou, Jianwei

AU - Sætrom, Pål

AU - Nielsen, Boye Schnack

AU - Kirschner, Michaela B.

AU - Krokan, Hans E.

AU - Papadimitrakopoulou, Vassiliki

AU - Tsamardinos, Ioannis

AU - Røe, Oluf D.

PY - 2016/10/19

Y1 - 2016/10/19

N2 - The goal of biomarker research is to identify clinically valid markers. Despite decades of research there has been disappointingly few molecules or techniques that are in use today. The "1st International NTNU Symposium on Current and Future Clinical Biomarkers of Cancer: Innovation and Implementation", was held June 16th and 17th 2016, at the Knowledge Center of the St. Olavs Hospital in Trondheim, Norway, under the auspices of the Norwegian University of Science and Technology (NTNU) and the HUNT biobank and research center. The Symposium attracted approximately 100 attendees and invited speakers from 12 countries and 4 continents. In this Symposium original research and overviews on diagnostic, predictive and prognostic cancer biomarkers in serum, plasma, urine, pleural fluid and tumor, circulating tumor cells and bioinformatics as well as how to implement biomarkers in clinical trials were presented. Senior researchers and young investigators presented, reviewed and vividly discussed important new developments in the field of clinical biomarkers of cancer, with the goal of accelerating biomarker research and implementation. The excerpts of this symposium aim to give a cutting-edge overview and insight on some highly important aspects of clinical cancer biomarkers to-date to connect molecular innovation with clinical implementation to eventually improve patient care.

AB - The goal of biomarker research is to identify clinically valid markers. Despite decades of research there has been disappointingly few molecules or techniques that are in use today. The "1st International NTNU Symposium on Current and Future Clinical Biomarkers of Cancer: Innovation and Implementation", was held June 16th and 17th 2016, at the Knowledge Center of the St. Olavs Hospital in Trondheim, Norway, under the auspices of the Norwegian University of Science and Technology (NTNU) and the HUNT biobank and research center. The Symposium attracted approximately 100 attendees and invited speakers from 12 countries and 4 continents. In this Symposium original research and overviews on diagnostic, predictive and prognostic cancer biomarkers in serum, plasma, urine, pleural fluid and tumor, circulating tumor cells and bioinformatics as well as how to implement biomarkers in clinical trials were presented. Senior researchers and young investigators presented, reviewed and vividly discussed important new developments in the field of clinical biomarkers of cancer, with the goal of accelerating biomarker research and implementation. The excerpts of this symposium aim to give a cutting-edge overview and insight on some highly important aspects of clinical cancer biomarkers to-date to connect molecular innovation with clinical implementation to eventually improve patient care.

KW - Bioinformatics

KW - Circulating biomarkers

KW - Circulating tumor cells

KW - DNA repair

KW - Early detection

KW - Early diagnosis

UR - http://www.scopus.com/inward/record.url?scp=84992130192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992130192&partnerID=8YFLogxK

U2 - 10.1186/s12967-016-1059-6

DO - 10.1186/s12967-016-1059-6

M3 - Article

VL - 14

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 295

ER -